Literature DB >> 23265693

Can we produce true tolerance in patients with food allergy?

M Cecilia Berin1, Lloyd Mayer.   

Abstract

Immune tolerance is defined as nonresponsiveness of the adaptive immune system to antigens. Immune mechanisms preventing inappropriate immune reactivity to innocuous antigens include deletion of reactive lymphocytes and generation of regulatory T (Treg) cells. The normal response to food antigens is the generation of antigen-specific Treg cells. In patients with food allergy, the dominant immune response is a T(H)2-skewed T-cell response and the generation of food-specific IgE antibodies from B cells. It is not known whether a failure of the Treg cell response is behind this inappropriate immune response, but interventions that boost the Treg cell response, such as mucosal immunotherapy, might lead to a restoration of immune tolerance to foods. Tolerance has been notoriously difficult to restore in animal disease models, but limited data from human trials suggest that tolerance (sustained nonresponsiveness) can be re-established in a subset of patients. Furthermore, studies on the natural history of food allergy indicate that spontaneous development of tolerance to foods over time is not uncommon. The current challenge is to understand the mechanisms responsible for restoration of natural or induced tolerance so that interventions can be developed to more successfully induce tolerance in the majority of patients with food allergy.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23265693      PMCID: PMC3807570          DOI: 10.1016/j.jaci.2012.10.058

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  105 in total

1.  Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria.

Authors:  M Rescigno; M Urbano; B Valzasina; M Francolini; G Rotta; R Bonasio; F Granucci; J P Kraehenbuhl; P Ricciardi-Castagnoli
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.

Authors:  Omid Akbari; Gordon J Freeman; Everett H Meyer; Edward A Greenfield; Tammy T Chang; Arlene H Sharpe; Gerald Berry; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

3.  Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease.

Authors:  Thomas A Kraus; Lisa Toy; Lisa Chan; Joseph Childs; Lloyd Mayer
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

4.  The safety and efficacy of sublingual and oral immunotherapy for milk allergy.

Authors:  Corinne A Keet; Pamela A Frischmeyer-Guerrerio; Ananth Thyagarajan; John T Schroeder; Robert G Hamilton; Stephen Boden; Pamela Steele; Sarah Driggers; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2011-11-30       Impact factor: 10.793

5.  Inhalation tolerance is induced selectively in thoracic lymph nodes but executed pervasively at distant mucosal and nonmucosal tissues.

Authors:  David Alvarez; Filip K Swirski; Teng-Chih Yang; Ramzi Fattouh; Ken Croitoru; Jonathan L Bramson; Martin R Stämpfli; Manel Jordana
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

6.  CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization.

Authors:  Femke van Wijk; Sanne Hoeks; Stefan Nierkens; Stef J Koppelman; Peter van Kooten; Louis Boon; Léon M J Knippels; Raymond Pieters
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

7.  Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts.

Authors:  Lucie Mondoulet; Vincent Dioszeghy; Jeroen A J Vanoirbeek; Benoit Nemery; Christophe Dupont; Pierre-Henri Benhamou
Journal:  Int Arch Allergy Immunol       Date:  2010-10-20       Impact factor: 2.749

8.  Positional cloning of the APECED gene.

Authors:  K Nagamine; P Peterson; H S Scott; J Kudoh; S Minoshima; M Heino; K J Krohn; M D Lalioti; P E Mullis; S E Antonarakis; K Kawasaki; S Asakawa; F Ito; N Shimizu
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

9.  Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein.

Authors:  Wayne G Shreffler; Niya Wanich; Marla Moloney; Anna Nowak-Wegrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

10.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

Authors:  Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  21 in total

Review 1.  Evolution of Immune Responses in Food Immunotherapy.

Authors:  Johanna M Smeekens; Michael D Kulis
Journal:  Immunol Allergy Clin North Am       Date:  2019-11-06       Impact factor: 3.479

2.  Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes.

Authors:  Eugene V Ravkov; Igor Y Pavlov; Thomas B Martins; Gerald J Gleich; Lori A Wagner; Harry R Hill; Julio C Delgado
Journal:  Hum Immunol       Date:  2013-08-28       Impact factor: 2.850

Review 3.  Engineering the Microbiome: a Novel Approach to Immunotherapy for Allergic and Immune Diseases.

Authors:  Nan Shen; Jose C Clemente
Journal:  Curr Allergy Asthma Rep       Date:  2015-07       Impact factor: 4.806

4.  Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients.

Authors:  Jun Liu; Feng-Hong Chen; Shu-Qi Qiu; Li-Tao Yang; Huan-Ping Zhang; Jiang-Qi Liu; Xiao-Rui Geng; Gui Yang; Zhi-Qiang Liu; Jing Li; Zhi-Gang Liu; Hua-Bin Li; Ping-Chang Yang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

5.  Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis.

Authors:  Leticia Tordesillas; Lucie Mondoulet; Ana Belen Blazquez; Pierre-Henri Benhamou; Hugh A Sampson; M Cecilia Berin
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

Review 6.  Oral Tolerance Development and Maintenance.

Authors:  Erik Wambre; David Jeong
Journal:  Immunol Allergy Clin North Am       Date:  2017-10-26       Impact factor: 3.479

7.  Forkhead box protein 3 demethylation is associated with tolerance induction in peanut-induced intestinal allergy.

Authors:  Meiqin Wang; Ivana V Yang; Elizabeth J Davidson; Anthony Joetham; Katsuyuki Takeda; Brian P O'Connor; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

Review 8.  Emerging therapies for food allergy.

Authors:  Corinne A Keet; Robert A Wood
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

9.  Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy.

Authors:  Magali Noval Rivas; Oliver T Burton; Petra Wise; Louis-Marie Charbonnier; Peter Georgiev; Hans C Oettgen; Rima Rachid; Talal A Chatila
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

Review 10.  Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.

Authors:  O Palomares; M Martín-Fontecha; R Lauener; C Traidl-Hoffmann; O Cavkaytar; M Akdis; C A Akdis
Journal:  Genes Immun       Date:  2014-07-24       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.